Stockland posted a strong FY25 result and guidance, highlighting growth potential in residential and commercial property, while addressing funding concerns
Michael Gable of Fairmont Equities sees momentum building for uranium pricing and stocks with Bannerman shares ready to rally past recent highs
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
A higher interest rate environment puts corporate balance sheets and cash flows back in focus as companies in need to refinance debt are facing an extra cost challenge
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
Global conditions are ripe for a shift in corporate earnings, says MFS’ Robert Almeida, with consequences for relative performances in diverging equity markets
Sigma Healthcare’s transformational merger with Chemist Warehouse provides for strong growth in sales, earnings, synergies and store-count in FY26 and beyond
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
It’s Australia’s Private-Sector Productivity Trap: Why Capital Shallowing Could Blindside Investors